Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

NCT01350362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: tideglusib
DRUG: tideglusib
DRUG: tideglusib
DRUG: Placebo

Sponsor

Noscira SA

Collaborators

[object Object]